Clinical trial
Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome…
NCT00455403 · Washington University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00455403 |
|---|---|
| Title | Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS) |
| Official title | Genotoxic Stress, Atherosclerosis, and Metabolic Syndrome- Aim 3 |
| Acronym | ARCH-MS |
| Lead sponsor | Washington University School of Medicine, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH Singulex Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Metabolic Syndrome X, Overweight, Hypertension, Dyslipidemias, Prediabetic State |
| Intervention type | Drug |
| Interventions | Chloroquine, Placebo Comparator |
| Enrollment | 357 |
| Start date | Apr 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Apr 3, 2007 |
| Last update posted | Dec 15, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: